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Abstracts / Osteoarthritis and Cartilage 23 (2015) A82eA416A196chondrocytes (ACs) and its regulatory mechanisms remain unclear. This
study aimed to explore epigenetic regulatory mechanisms of age-rela-
ted SOX9 expression in ACs of mice, spanning from the embryonic stage
to 18 months of age.
Methods: The hip and shoulder joints of wild type BALB/c mice were
harvested at embryonic day 16.5 and 1, 2, 6, 12 and 18 months for
histopathological and immunohistochemical analyses. Femoral and
humeral head cartilage from the same age groups was used for chon-
drocyte isolation, gene expression, methylated DNA immunoprecipita-
tion or chromatin immunoprecipitation assays to examine epigenetic
changes in the promoter region of the Sox9 gene. siRNA-mediated
knockdown of the histone lysine-speciﬁc demethylases-1 gene (Lsd1)
and 5-azacytidine treatment were performed in cultured ACs.
Results: Sox9 mRNA and protein were highly expressed in ACs during
joint development but signiﬁcantly decreased at 2-18 months of age. No
histopathological features of osteoarthritis were observed in examined
joints by 18 months. Epigenetic DNA methylation and histone methyl-
ation are both associated with the age-dependent SOX9 expression.
Knockdown of Lsd1 is sufﬁcient to up-regulate SOX9 expression in ACs of
adult mice through increased recruitment of H3K4me2 (a histone
modiﬁcation for transcriptional activation) in the promoter region of the
Sox9 gene. However, the reduction of DNA methylation in the Sox9
promoter region induced by 5-azacytidine treatment in cultured ACs did
not increase Sox9 expression. The data suggest that reduction of SOX9
expression in ACs of adult mice is primarily regulated by H3K4me2.
Conclusions: These results suggest that SOX9 expression in mouse ACs
is signiﬁcantly decreased after the completion of joint development due
to reduced demands for SOX9. This developmental switch in SOX9
expression in mouse articular cartilage is primarily regulated by epi-
genetic histone methylation.
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NOVEL SUSCEPTABILITY LOCI FOR OSTEOARTHRITIS OF THE HAND:
VARIANTS IN CODING EN GENE REGULATORY REGIONS
C.G. Boer, M. de Kruijf, L. Broer, A. Hofman, A.G. Uitterlinden,
J.J. van Meurs. Erasmus Med. Ctr., Rotterdam, Netherlands
Purpose: Osteoarthritis (OA) of the hand, is to a large extend, genet-
ically determined. However, despite the large GWAS efforts into OA over
the last years only one locus has been found to be associated to hand OA.
We here aim to identify novel genes and pathways involved in the
etiology of hand OA.
Methods: We conducted a genome-wide association study of hand OA
in a discovery set of 10,155 participants from the three Rotterdam Study
cohorts (RS1, RS2 and RS3) using standardized age and gender adjust-
ments. We have used a quantitative bilateral hand OA phenotype,
summing all KL-scores of the hand joints for both hands (min score: 0,
max score: 128). EasyQC was used to conduct quality control across
cohorts. Results were combined in a jointedmeta-analysis using inverse
variance weighting. Genome-wide signiﬁcant signals were analyzes for
enrichment in genomic regulatory regions, using data from the ENCODE
and Roadmap epigenetics project.
Results: The discovery analysis yielded 16 loci with suggestive evidence
for association (P<5*10-6 ) and another 3 loci with genome-wide sig-
niﬁcant association (p<5*10-8). These novel genome-wide signiﬁcant
loci include SNPs in or near the MGP, PTHLH and APBB2 genes. The risk
alleles of MGP, PTHLH and APBB2 genes had a higher KL-sum score
compared to the reference allele (delta KL-score was 7, 6, and 23
respectively) MGP codes for Matrix Gla Protein and is important for
limiting calciﬁcation in tissues. Mutations in the MGP gene have been
associated to Keutel Syndrome, which is characterized by abnormal
mineralization of cartilage tissue. We here identiﬁed a SNP resulting in a
protein-change to be associated with hand OA. The identiﬁed SNPs in
the PTHLH-locus and the APBB2-locus co-localize with enhancer his-
tone markers in osteoblast and chondrogenic cells from the Roadmap
and ENCODE database, suggesting a potential gene regulatory function
for these SNPs.
Conclusions:We identiﬁed 3 loci to be associated to hand OA, a coding
variant in theMPG gene and two intronic variants in APBB2 and CCDC91
located near gene regulatory marks speciﬁc for bone and/or cartilage. In
addition, we have also found 16 loci suggestively associated to hand OA.
Future analysis will consist of validation of our ﬁndings in other cohorts
and further functional assessment and pathway analyses of the iden-
tiﬁed variants310
SMAD3 IS UP-REGULATED IN HUMAN OSTEOARTHRITIC CARTILAGE
INDEPENDENT OF PROMOTER DNA METHYLATION
E. Aref-Eshghi, M. Liu, S.B. Razavi-Lopez, K. Hirasawa, P.E. Harper,
G. Martin, A. Furey, R. Green, P. Rahman, G. Zhai. Mem. Univ. of
Newfoundland, St John's, NL, Canada
Purpose: We previously reported that SMAD3 was associated with the
total burden of radiographic osteoarthritis (OA). SMAD3 is a mediator of
TGF-b signalling pathway that is known to be involved in the cartilage
maintenance and repair. SMAD3 knocked-out mice are deﬁcient for
Collagen and Aggrecan, and develop OA-like features in the joints. The
aim of the present study was to investigate the SMAD3 gene expression
in osteoarthritic and healthy human cartilage and to examine whether
the gene expression is regulated by the promoter DNA methylation.
Methods: Osteoarthritic cartilage samples were collected from patients
who underwent total hip/knee joint replacement surgery due to pri-
mary OA. Healthy cartilage samples were obtained from patients with
hip fracture without any evidence of hip OA. DNA and RNA were
extracted from the cartilage samples using Qiagen’s AllPrep DNA/RNA
Mini Kit. Quantitative PCR experiment was done using ABI-7500 real
time PCR system to measure RNA expression after cDNA synthesis by
ThermoScript cDNA synthesis kit. DNA Methylation was assayed by
Sequonom’s EpiTYPER after DNA bisulphate conversion using Qiagen’s
EpiTect Bisulﬁte Kit. Mann-Whitney test was utilized to examine the
association between OA cases and controls for SMAD3 expression and
its promoter DNA methylation levels. Spearman's rank correlation
analysis was performed to examine the association between the pro-
moter methylation and gene expression. A P-value less than 0.05 was
considered as signiﬁcant.
Results: A total of 49 OA patients (38 hip OA and 11 knee OA) and 51
controls were included in the study. Mean age was 64.4 in OA patients
and 78.7 in controls. Four CpG sites, located ~450bp upstream of the
ﬁrst SMAD3 exon, were assayed, and we found no difference in meth-
ylation between OA cases and controls after adjusting for age. The
expression experiment was performed for 38 patients with OA (32 hips
and 6 knees) and 28 healthy controls, and we found that the SMAD3
gene was expressed in OA cartilage on average 1.8 times higher than
controls (p¼0.0005). Similar results were obtained when we looked at
hip and knee OA separately (p¼0.01). We found no association between
SMAD3 expression and the methylation at the promoter region of the
gene.
Conclusions: Our study demonstrated that SMAD3 is up-regulated in
OA. This up-regulation, however, cannot be explained by the changes in
the promoter DNAmethylation. Given that TGF-b/SMAD3 pathwaymay
play a protective role in the cartilage, the up-regulation of SMAD3 is
more likely due to the consequence of OA, thus reﬂecting repairing
activity stimulated by the cartilage lesion in OA.
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EFFECTS OF HYPOXIA ON ANABOLIC AND CATABOLIC GENE
EXPRESSION AND DNA METHYLATION IN OA CHONDROCYTES
K. Alvarez y, M.C. de Andres y, A. Takahashi y,z, R.O. Oreffo y. yUniv. of
Southampton. Faculty of Med., Southampton, United Kingdom; z Tohoku
Univ. Sch. of Med., Sendai, Japan
Purpose: Osteoarthritis (OA) is a clinical syndrome characterized by
joint pain, functional limitation and reduced quality of life. An essential
feature if the underlying pathogenesis of OA is an imbalance of anabolic
and catabolic activity leading to progressive loss and destruction of
extracellular matrix of articular cartilage. Cartilage is an avascular and
aneural tissue. Chondrocytes thrive in this restricted environment of
low oxygen tension and poor nutrient availability, which has led to
suggestion that hypoxia, may be a protective mechanism against the
development of (OA). There is a growing body of evidence to support
the role of epigenetic factors in the pathogenesis of OA. However, few
studies have investigated the epigenetic-OA process within a hypoxic
environment. The current study has investigated the effects of hypoxia
on gene expression and DNA methylation of anabolic and catabolic
genes involved in the pathogenesis of OA.
Methods: Chondrocytes extracted from OA femoral heads were incu-
bated in normoxia and hypoxia (20% and 2% oxygen concentrations
respectively). Interleukin 1-beta (IL-1b) plus oncostatin M (OSM), 5-
azadeoxycytidine (5-aza-dC) or media alone (control) were added twice
weekly to the incubated samples. After 5 weeks, levels of Collagen type
Comparison of the allele frequencies of the MIF microsatellite
Controls THR
Women Men Women Men
Allele Count Freq Count Freq Count Freq Count Freq
5 1402 25.4 1439 25.3 671 23.1 474 24.3
6 3453 62.5 3574 62.7 1853 63.7 1237 63.5
7 669 12.1 685 12.0 386 13.3 237 12.2
Total 5524 5698 2910 1948
Abstracts / Osteoarthritis and Cartilage 23 (2015) A82eA416 A197IX (COL9A1), IL1B, and matrix metalloproteinase-13 (MMP13) gene
expression were measured using SYBR Green-based qRT-PCR and were
correlated with methylation status analysed by pyrosequencing
methodology.
Results: Hypoxia resulted in a >50-fold and >10-fold increase in rela-
tive expression of COL9A1 and IL1B respectively. This was inversely
correlated to the DNA methylation status of these genes. Expression of
MMP13 was reduced at 2% oxygen tension in control cells. Relative
expression of MMP13 increased in cells stimulated with IL-1b and 5-
aza-dC in normoxic conditions, and this effect was eliminated at low
oxygen tension although no correlation with methylation status was
observed.
Conclusions: These ﬁndings demonstrate a role for hypoxia in the
regulation anabolic and catabolic gene expression and the inﬂuence of
changes in DNA methylation. These results further support the role of
epigenetics in OA and critically, highlight the complex relationship
between the physiological environment of cartilaginous cells and the
osteoarthritic process with implications for therapeutic intervention
and our understanding of OA pathophysiology.
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VALIDATION OF THE ASSOCIATION OF A FUNCTIONAL
MICROSATELLITE IN MACROPHAGE MIGRATION FACTOR WITH HIP
OA
A. Gonzalez, L. Vidal, M. Calaza. Hosp. Clinico Univ.rio de Santiago,
Santiago de Compostela, Spain
Purpose: Microsatellites are not amenable for high-throughput geno-
typing and have been excluded from GWAS. However, several micro-
satellites have been found to affect expression of nearby genes and a
couple of them, in the asporin and BMP5 genes, have been associated
with susceptibility to OA in multiple studies. In a recent exploration of
functional microsatellites we found association of the -794 CATT
microsatellite in the MIF gene with hip OA in 1782 patients compared
with 1878 healthy controls of European ancestry. Replication in other
patient collections was hampered by the lack of a method to obtain the
genotypes without actually performing the laboratory tests. Therefore,
we aimed to develop an imputation methodology for this microsatellite
using the genotypes of SNPs in linkage disequilibrium and to apply it for
validation.
Methods: In our previous study of the MIF microsatellite, we had
included 1090 samples that were also in the arcOGENGWAS. Genotypes
of the 130 SNPs in the linkage disequilibrium region surrounding the
microsatellite in these samples were used as source of haplotype
information. Imputation was done with Impute2 with modiﬁcations
allowing estimation of the probabilities for the number of copies of each
microsatellite allele and their posterior combination. Performance of
this procedure was evaluated in 10 replicates of training, with 90 % of
the samples, and testing of accuracy in the remaining 10 % of the
samples with known microsatellite genotypes. Once concordance of
imputed genotypes with tested genotypes was established, the
approach was applied for the imputation of the MIF microsatellite in
5667 population controls from Wellcome Trust Case-Control Con-
sortium (WTCCC) and in 2466 hip OA cases from arcOGEN (all of them
of European UK ancestry). In addition, we have validated the functional
effect of the MIF microsatellite on the plasma levels of MIF in 361
healthy control samples by ELISA (R&D Systems) from subjects that
were either homozygous for the 5 repeat or the 6 repeat alleles. MIF
microsatellite allele frequencies were compared with POWERMARKER
and differences in plasma levels of MIF were analyzed with ANOVA
using Statistica 7.0 (StatSoft).
Results: There was a microsatellite allele with frequency lower than 1%
that was not included in the imputation. The genotypes of the other
three alleles were imputedwith sufﬁcient accuracy (91.6 %) and call rate
in the reference samples (98.8). However, other microsatellites showed
that the procedure will require further reﬁnements to attain this per-
formance for microsatellites with more alleles. Application of this
procedure to theWTCCC and arcOGEN samples produced genotypes for
99.0 % of the samples. Comparison of the allelic frequencies showedsigniﬁcant differences between hip OA and controls in women (Table 1)
following the same pattern found in our previous study, with the ﬁve
repeats allele less frequent in the patients than in the controls (OR ¼
0.88, [95% CI] 0.79 to 0.98, P ¼ 0.018). However, no difference was
appreciated in men or between control women andmen as it was in our
previous study. This contrast between studies could be attributed to the
use of OA-free controls in the previous study and population controls
here.
Analysis of MIF in plasma of healthy controls showed higher levels in
the homozygous for the 5 repeat allele (3.6 ng/mL) than for the 6 repeat
allele (2.7 ng/mL; P ¼ 0.00025) following the direction previously
reported by other authors andwithout differences betweenwomen and
men.
Conclusions: A new method to impute genotypes of microsatellites
with three alleles based on SNP genotypes has been developed. It has
shown good call rate and accuracy. This procedure allowed us to vali-
date the association of the MIF microsatellite with hip OA in a large
number of cases and controls. Concordance with our previous study
was obtained in women, but not in men. Higher MIF levels were found
in the subjects with the hip OA protective allele. These results should
contribute to deﬁne the role of MIF, an important cytokine, in the OA
pathology.Health Services Research
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ALTERNATIVE SURVIVAL ANALYSIS METHODS TO ESTIMATE TIME TO
REVISION FOLLOWING HIP AND KNEE ARTHROPLASTY: CAN THE
KAPLAN-MEIER METHOD COMPETE?
S. Lacny y, P.D. Faris z,x, E. Bohm k,¶, L.J. Woodhouse#,yy,
O. Robertsson zz, D.A. Marshall y,xx. yUniv. of Calgary, Calgary, AB,
Canada; zAlberta Hlth.Services, Calgary, AB, Canada; xAlberta Bone and
Joint Hlth.Inst., Calgary, AB, Canada; kUniv. of Manitoba, Winnipeg, MB,
Canada; ¶Concordia Hip and Knee Inst., Winnipeg, MB, Canada; #Univ.
of Alberta, Edmonton, AB, Canada; yyAlberta Hlth.Services Bone and
Joint Hlth.Strategic Clinical Network, Edmonton, AB, Canada; zz Swedish
Knee Arthroplasty Register, Univ. of Lund, Lund, Sweden; xxMcCaig Inst.
for Bone and Joint Hlth., Calgary, AB, Canada
Purpose: With increased longevity and frequency with which joint
replacements are being performed on younger, more physically active
patients, it has become common for patients to outlive the life of their
prosthesis and require a revision. Measuring the cumulative incidence
of revision (i.e., revision rate) provides a measure of the rate of failure
of joint replacements and can be used to project future demand for
revisions. Due to varying patient follow-up times and censoring, sur-
vival analysis is required to estimate revision rates. The Kaplan-Meier
(KM) method is the most commonly applied survival analysis method.
However, it does not account for the competing risk of death and
consequently overestimates the cumulative incidence of revision. This
is problematic given the high rate of competing risks, especially in
older patients receiving joint replacements. Although alternative
methods that account for competing risks have been developed, they
are rarely used within the arthroplasty literature or among joint
replacement registries. Our objective was to assess alternative meth-
ods for estimating the cumulative incidence of revision through
application to population-based cohorts. We evaluated these methods
